Maria Meritxell Roca Mora: DOACs Show Promise Over VKAs in Kidney Transplant Recipients
Meta Analysis Academy shared on X:
”New Meta Master Publication Alert
A systematic review and Meta-Analysis of 5 studies (n=959 patients) compared direct-acting oral anticoagulants (DOACs) vs. vitamin K antagonists (VKAs) in kidney transplant recipients (KTRs).
Key findings:
- DOACs reduced major bleeding
- DOACs lowered mortality
- No significant difference in VTE risk, in graft failure and kidney function (eGFR)
Conclusion: DOACs may be an effective anticoagulation strategy in KTRs, offering reduced bleeding and mortality compared with VKAs, though evidence quality remains low-to-moderate.”
Read the full article here.
Article: Safety and efficacy of direct oral anticoagulants in kidney transplant recipients: A systematic review and meta-analysis
Authors: Maria Meritxell Roca Mora, Andre Milani Reis, Filipe Piazzi Tavares, Lídia Santos Oliveira, Amanda Godoi, Patricia Viana, Juliano Riella
Stay updates on the latest advances in the field of anticoagulation with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy